On the other hand, Li-7, a unique CD13(+) HCC line that was developed by cancer stem cell differentiation in culture, has been shown to be resistant to Sorafenib due to the high expression of P-gp and MRP2 [11]. This evidence concerns the gene PGP and hepatocellular carcinoma.